This opening session from the International Society for Diseases of the Esophagus webinar provides a global overview of lymphadenectomy practices in esophageal cancer. Dr. C.S. Pramesh outlines key differences between 2-field and 3-field lymphadenectomy, emphasizing how regional variation, tumor histology (squamous cell carcinoma vs adenocarcinoma), and evolving perioperative therapies influence surgical decision-making. The session highlights the ongoing debate regarding the extent of lymph node dissection and underscores the need for stronger long-term outcomes data to guide best practice.


You may also like

Treatment of T1 Cancer Associated with Barrett's Esophagus - Endoscopic Resection Should Be Done – Michael Bourke
•
3views•
0likes
Listen to Dr. Michael Bourke present during the Esophageal Debates Session, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this session, including: Treatment of T1 Cancer ...
Log in to watch
Esophageal Cancer: Screening and Endoscopic Therapies - Anthony Gamboa
•
14views•
1likes
Anthony Gamboa of Vanderbilt University Medical Center (United States) presented on early detection and intervention strategies for esophageal cancer, focusing on Barrett's esophagus as a precancerous condition. He discussed screening methods ...
Researching The Use Biomarkers for Managing Barrett’s Esophagus
•
36views•
0likes
Watch Dr. David Lui interview Professor Sheila K. Krishnadath discuss the recent approval of a research project focusing on biomarkers. The grant is the culmination of many years of research looking at biomarkers as a means of making clinical ...
Long Term PPI Therapy: Controversies in GERD Part 1 with Kerry Dunbar
•
15views•
0likes
Gastroesophageal Reflux Disease (GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact in the patient’s quality of life. The typical symptoms are ...
Post-operative Outcomes after Chemoradiation versus Chemotherapy: Surgical Results from the ESOPEC Trial – Olga Meier
•
2views•
0likes
Listen to Dr. Olga Meier present during the second Presidential Plenary Session comprising 2 state-of-the-art lectures by leaders in their respective fields (benign and malignant) followed by the top 2 submitted abstracts in each field. This ...
Log in to watch
Exploring Communication and Collaboration in our International, Multidisciplinary Esophageal Community – Walter Chan
•
1views•
0likes
Digital and social media play a crucial role in communication within the esophageal community, fostering collaboration among professionals and patients. With nearly 70% of the global population using social media, it serves as a vital tool for ...
Log in to watch
Multidisciplinary Conference of Benign Esophageal Disease: Case 3
•
5views•
0likes
Listen to the panel discussion on Case 3 of 5 of the Multidisciplinary Tumour Board, moderated by Mark Smithers and Nicholas Shaheen. The international panel of experts included: Gastroenterology panelists: Peter Kahrilas, Sachin Wani, Vani ...
Log in to watch
Giant Paraoesophageal Hernia - When is Resection Justified and What Are the Options? – Sheraz Markar
•
4views•
0likes
Listen to Dr. Sheraz Markar present during the Giant Hiatus Hernia Session, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this session, including: Fundoplication after ...
Log in to watch
Oesophageal Cancer Surgery in Australia: Where It Has Come from and Where It Is Heading – Mark Smithers
•
0views•
0likes
Listen to Dr. Mark Smithers present during the AANZGOSA-ISDE Joint Session on Challenges and Dilemmas from the Experts, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this ...
Log in to watch
Page 15 of 17